FMR LLC 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-11 09:09 am Sale | 2023-12-08 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 0 0.000% | -1,326,267 (Position Closed) | Filing |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 1,326,267 7.041% | -1,125,985 (-45.92%) | Filing |
| 2023-08-10 08:19 am Purchase | 2023-08-09 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 2,452,252 14.750% | 2,325,827 (+1839.69%) | Filing |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 126,425 2.257% | 126,425 (New Position) | Filing |